• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunic, Inc. - Common Stock (NQ:IMUX)

1.240 +0.070 (+5.98%)
Streaming Delayed Price Updated: 2:04 PM EDT, Apr 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,697,290
Open 1.170
Bid (Size) 1.240 (2,800)
Ask (Size) 1.250 (4,200)
Prev. Close 1.170
Today's Range 1.170 - 1.340
52wk Range 0.5062 - 1.510
Shares Outstanding 26,249,439
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Stock Market Today, March 24: Oil, AI, and Private Credit Fears Weigh on Markets ↗
March 24, 2026
On March 24, 2026, choppy, oil-driven trading and fresh AI disruption fears pressured major U.S. indexes. 
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
Which stocks have an unusual volume on Tuesday? ↗
February 17, 2026
Via Chartmill

Performance

YTD
+112.7%
+112.7%
1 Month
+6.0%
+6.0%
3 Month
+87.5%
+87.5%
6 Month
+38.6%
+38.6%
1 Year
+35.1%
+35.1%

More News

Read More
News headline image
Immunic Stock Jumps After Pricing $400 Million Private Placement ↗
February 13, 2026
Via Benzinga
Traders are paying attention to the gapping stocks in Friday's session. ↗
February 13, 2026
Via Chartmill
What's going on in today's pre-market session ↗
February 13, 2026
Via Chartmill
News headline image
Why Did IMUX Stock Surge 33% Pre-Market Today? ↗
February 13, 2026
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
November 18, 2025
Via Benzinga
News headline image
This Electronic Arts Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗
September 29, 2025
Via Benzinga
News headline image
This VSE Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
September 29, 2025
Via Benzinga
News headline image
Immunic (IMUX) Q2 Loss Widens 25% ↗
August 07, 2025
Via The Motley Fool
News headline image
Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial ↗
July 07, 2025
Via Stocktwits
News headline image
Immunic to Participate in Scientific and Industry Conferences in May ↗
July 07, 2025
Via Stocktwits
Topics Economy
News headline image
Immunic, Inc. Announces Proposed Public Offering ↗
July 07, 2025
Via Stocktwits
Topics Regulatory Compliance
News headline image
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering ↗
July 07, 2025
Via Stocktwits
News headline image
Immunic to Participate in Investor, Scientific and Industry Conferences in June ↗
July 02, 2025
Via Stocktwits
Topics Intellectual Property
News headline image
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering ↗
July 02, 2025
Via Stocktwits
News headline image
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS ↗
July 02, 2025
Via Stocktwits
News headline image
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis ↗
July 02, 2025
Via Stocktwits
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
May 29, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
May 29, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
May 28, 2025
Via Benzinga
News headline image
Wednesday's session: top gainers and losers ↗
April 30, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
April 30, 2025
Via Benzinga
News headline image
Wednesday's session: gap up and gap down stocks ↗
April 30, 2025
Via Chartmill
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
April 30, 2025
Via Chartmill

Frequently Asked Questions

Is Immunic, Inc. - Common Stock publicly traded?
Yes, Immunic, Inc. - Common Stock is publicly traded.
What exchange does Immunic, Inc. - Common Stock trade on?
Immunic, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Immunic, Inc. - Common Stock?
The ticker symbol for Immunic, Inc. - Common Stock is IMUX on the Nasdaq Stock Market
What is the current price of Immunic, Inc. - Common Stock?
The current price of Immunic, Inc. - Common Stock is 1.240
When was Immunic, Inc. - Common Stock last traded?
The last trade of Immunic, Inc. - Common Stock was at 04/13/26 02:04 PM ET
What is the market capitalization of Immunic, Inc. - Common Stock?
The market capitalization of Immunic, Inc. - Common Stock is 32.55M
How many shares of Immunic, Inc. - Common Stock are outstanding?
Immunic, Inc. - Common Stock has 33M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap